Human immunoglobulin therapy for preeclampsia associated with lupus anticoagulant and anticardiolipin antibody.


Journal Article

A patient with lupus anticoagulant and anticardiolipin antibody developed preeclampsia at 24 weeks' gestation. Therapy with human immunoglobulin (Ig) resulted in stabilization of preeclampsia and suppression of the lupus anticoagulant. Anticardiolipin antibody titers were partially suppressed. Preeclampsia worsened at 32 weeks' gestation, and a healthy infant was delivered. For patients with preeclampsia secondary to lupus anticoagulant before the fetus is viable, human Ig is a potential therapeutic option.

Full Text

Cited Authors

  • Katz, VL; Thorp, JM; Watson, WJ; Fowler, L; Heine, RP

Published Date

  • November 1990

Published In

Volume / Issue

  • 76 / 5 Pt 2

Start / End Page

  • 986 - 988

PubMed ID

  • 2120649

Pubmed Central ID

  • 2120649

Electronic International Standard Serial Number (EISSN)

  • 1873-233X

International Standard Serial Number (ISSN)

  • 0029-7844


  • eng